Companies: 10,795·Total market cap: $144.5T
Decibel Therapeutics, Inc.

Decibel Therapeutics, Inc.

DBTXNASDAQHealthcare
$4.91
$-0.04(-0.81%)
Market Cap$123373079
P/E Ratio
52W High$5.4
52W Low$1.61
Overview

Decibel Therapeutics, Inc.(DBTX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · DBTX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.04B$0.03B$0.03B$0.03B$0.03B
G&A Expenses$0.02B$0.02B$0.01B$0.01B$0.01B
Total Operating Expenses$0.06B$0.05B$0.04B$0.04B$0.04B
Operating Income($0.06B)($0.05B)($0.04B)($0.04B)($0.04B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.06B)($0.05B)($0.04B)($0.04B)($0.04B)
Income Tax Expense$0.00B$0.00B($0.00B)($0.00B)$0.00B
Net Income($0.06B)($0.05B)($0.04B)($0.04B)($0.04B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.52$-2.38$-1.63$-5.61$-4.98
Wtd Avg Shares0.02B0.02B0.02B0.01B0.01B
EBITDA($0.06B)($0.05B)($0.04B)($0.04B)($0.04B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Decibel Therapeutics, Inc.

关于Decibel Therapeutics, Inc.(DBTX)损益表

Decibel Therapeutics, Inc.(DBTX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,DBTX实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.06B)(净利率—)。

常见问题

DBTX · 4 问

Decibel Therapeutics, Inc.(DBTX)2022财年营收为$0.00B,同比down—%。

DBTX revenueDBTX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09